Tuesday, January 31, 2012

Meningioma Awareness Day

Brain Science Foundation Patient Education Event for Spring.
In April, the 5th Meningioma Awareness Day is scheduled for Friday, April 27 and Saturday, April 28, 2012 at the Joseph B. Martin Conference Center at Harvard Medical School.

The event features a full day of educational presentations, lectures, and opportunities to meet others. The Friday evening program will provide one-on-one discussions between patients and medical experts who can answer their questions.

Meningioma Awareness Day brings together physicians and other health providers, researchers, Meningioma patients and their families/friends for mutual learning about the causes, detection, and treatment of the disease. This completely patient-centered event provides information and strategies for coping with this most common form of primary brain tumor.

While the exact program is still in its design phase, some topics covered will include the following themes:

Latest epidemiology research — what causes meningiomas and why?
Patient stories and experiences.
Treatment options.
Complete care—your path to wellness.
How the latest advances impact patients.
Managing symptoms.
Rehabilitation.

Meningioma Awareness Day aims to be a completely patient-focused event that covers all the key topics for patients and their loved ones. Time will be set aside for participants to meet and discuss issues with each other as well as with medical experts.

Online registration is currently open, and more information available by clicking here:

http://tinyurl.com/7n8skxm

Or contact them on 781-239-2903 should you have any questions!

2 comments:

alternative cancer treatments said...

Thanks for sharing your thoughts about Meningioma. It is very helpful that you have shared this wonderful article/blog to us.

alternative cancer treatments said...

Very informative, this is a new topic for me. My alternative cancer treatments center have discussed this with me way before year 2009 and this feels so refreshing for me. Thanks a lot.